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Stenotrophomonas maltophilia is an emerging Cystic Fibrosis (CF) lung pathogen, 
which displays high intrinsic resistance to a number of different antibiotics. 
Additionally, S. maltophilia is thought to increase antibiotic resistance by forming 
biofilms during infection. Biofilm disruption could promote clearance of the 
microorganism from CF-infected lungs. However, the genetic, biochemical and 
immunological mechanisms underlying S. maltophilia biofilm formation are not well 
understood. Secreted polysaccharides have been proven to form a vital component of 
the matrix that surrounds and protects biofilm bacteria. Hundreds of S. maltophilia 
mutants were generated by transposon mutagenesis and screened for strains with 
reduced polysaccharide secretion.. These strains were screened through the use of agar 
plates containing the polysaccharide-binding dye, Congo red. Experimental controls 
included a S. maltophilia wild-type strain (positive control) and a confirmed 
polysaccharide deficient mutant (negative control). A Congo red liquid binding assay 
was utilized to identify the amount of Congo red bound in the samples, which 
confirmed the amount of polysaccharide present in them. A total of 1,728 mutants were 
screened with 61 mutants showing reduced polysaccharide production. The mutants 
were further narrowed down to 8 samples showing the most consistent phenotype. 
Arbitrary-primed polymerase chain reactions (AP-PCR), followed by sequencing, will 
be performed on the selected samples in an effort to identify the genes mutated in 
polysaccharide deficient strains. We will also perform immunological assays in an 
effort to understand underlying immune responses to S. maltophilia. In order to 
determine the effects of the deletion of gpmA in S. maltophilia, we will be performing 
an in-vitro co-culture assay using the wild-type strain and the gpmA mutant strain. 
These studies will yield evidence to the molecular process involved in polysaccharide 
production, which could lead to mechanisms to disrupt biofilm formation in CF 
patients. 
 
